Fuller & Thaler Asset Management
SRPT icon

Fuller & Thaler Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Fuller & Thaler Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-63,856
Closed -$10.9M – 560
2020
Q4 		$10.9M Buy
63,856
+1,272
+2% +$188K 0.1% 191
2020
Q3 		$8.79M Sell
62,584
-46,386
-43% -$7.05M 0.11% 183
2020
Q2 		$17.5M Buy
108,970
+1,066
+1% +$145K 0.23% 117
2020
Q1 		$10.6M Sell
107,904
-2,413
-2% -$276K 0.18% 128
2019
Q4 		$14.2M Sell
110,317
-1,739
-2% -$176K 0.16% 143
2019
Q3 		$8.44M Sell
112,056
-202
-0.2% -$23.9K 0.1% 170
2019
Q2 		$17.1M Buy
112,258
+306
+0.3% +$37.2K 0.2% 126
2019
Q1 		$13.3M Sell
111,952
-20,815
-16% -$2.68M 0.17% 126
2018
Q4 		$14.5M Sell
132,767
-4,718
-3% -$590K 0.21% 112
2018
Q3 		$22.2M Sell
137,485
-8,369
-6% -$1.14M 0.23% 115
2018
Q2 		$19.3M Buy
145,854
+709
+0.5% +$66.9K 0.21% 108
2018
Q1 		$10.8M Sell
145,145
-5,005
-3% -$334K 0.13% 131
2017
Q4 		$8.35M Buy
+150,150
New +$7.95M 0.1% 143

Other funds holding SRPT

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fuller & Thaler Asset Management's SRPT Position: Q1 2021 in Review

Fuller & Thaler Asset Management sold out of Sarepta Therapeutics (SRPT) in Q1 2021, closing a stake of 63,856 shares — an estimated $10.9M sold.

Fuller & Thaler Asset Management first reported a position in SRPT in Q4 2017 and held it in 13 quarters. The position peaked at $22.2M in Q3 2018. 366 funds tracked by Wall St. Rank hold SRPT as of Q1 2021.

  • Fuller & Thaler Asset Management reported no remaining Sarepta Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 63,856 Sarepta Therapeutics shares in Q1 2021, an estimated $10.9M.
  • Fuller & Thaler Asset Management first reported a position in Sarepta Therapeutics in Q4 2017 and held it in 13 quarters.
  • Fuller & Thaler Asset Management's Sarepta Therapeutics position peaked at $22.2M in Q3 2018.
  • 366 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2021.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2021, filed 13 May 2021.